Deborah Finco

688 total citations
9 papers, 379 citations indexed

About

Deborah Finco is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Deborah Finco has authored 9 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in Deborah Finco's work include Biosimilars and Bioanalytical Methods (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and CAR-T cell therapy research (2 papers). Deborah Finco is often cited by papers focused on Biosimilars and Bioanalytical Methods (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and CAR-T cell therapy research (2 papers). Deborah Finco collaborates with scholars based in United States, United Kingdom and Switzerland. Deborah Finco's co-authors include George R. Gunn, M. Benjamin Hock, James B. Rottman, Joseph C. Beyer, Jennifer L. Rojko, Michael W. Leach, Meena Subramanyam, Viswanath Devanarayan, Susan Richards and Daniel Baltrukonis and has published in prestigious journals such as Clinical & Experimental Immunology, Cytokine and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

Deborah Finco

9 papers receiving 360 citations

Peers

Deborah Finco

IMMUN

RNMI

MB

ONCOL

PPCH

Naomi S. Falk United States

Christopher J. Elson United Kingdom

Ann Stuart United States

Amichai Schattner Israel

Jessica Stolp Australia

Joerg C. Prinz Germany

Debbie Roeleveld Netherlands

A Huber United States

Valerie Theobald United States

Neha Deshpande United States

Naomi S. Falk United States

Deborah Finco

123 ×0.5

IMMUN

122 ×0.8

RNMI

54 ×0.6

MB

24 ×0.3

ONCOL

11 ×0.3

PPCH

Citations per year, relative to Deborah Finco Deborah Finco (= 1×) peers Naomi S. Falk

Countries citing papers authored by Deborah Finco

Since Specialization

Citations

This map shows the geographic impact of Deborah Finco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Finco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Finco more than expected).

Fields of papers citing papers by Deborah Finco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Finco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Finco. The network helps show where Deborah Finco may publish in the future.

Co-authorship network of co-authors of Deborah Finco

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Finco. A scholar is included among the top collaborators of Deborah Finco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Finco. Deborah Finco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Sperinde, Gizette, et al.. (2020). Clinical Immunogenicity Risk Assessment Strategy for a Low Risk Monoclonal Antibody. The AAPS Journal. 22(3). 60–60. 5 indexed citations

2.

Gorovits, Boris, Daniel Baltrukonis, Indranil Bhattacharya, et al.. (2018). Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab. Clinical & Experimental Immunology. 192(3). 348–365. 61 indexed citations

3.

Grimaldi, Christine, Deborah Finco, Madeline Fort, et al.. (2016). Cytokine release: A workshop proceedings on the state-of-the-science, current challenges and future directions. Cytokine. 85. 101–108. 32 indexed citations

4.

Finco, Deborah, Christine Grimaldi, Madeline Fort, et al.. (2014). Cytokine release assays: Current practices and future directions. Cytokine. 66(2). 143–155. 64 indexed citations

5.

Leach, Michael W., James B. Rottman, M. Benjamin Hock, et al.. (2013). Immunogenicity/Hypersensitivity of Biologics. Toxicologic Pathology. 42(1). 293–300. 66 indexed citations

6.

Gupta, Shalini, Viswanath Devanarayan, Deborah Finco, et al.. (2011). Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics. Journal of Pharmaceutical and Biomedical Analysis. 55(5). 878–888. 89 indexed citations

7.

Zorbas, Mark, Susan Hurst, David L. Shelton, et al.. (2010). A multiple-dose toxicity study of tanezumab in cynomolgus monkeys. Regulatory Toxicology and Pharmacology. 59(2). 334–342. 24 indexed citations

8.

Finco, Deborah, Daniel Baltrukonis, Adrienne Clements‐Egan, et al.. (2010). Comparison of competitive ligand-binding assay and bioassay formats for the measurement of neutralizing antibodies to protein therapeutics. Journal of Pharmaceutical and Biomedical Analysis. 54(2). 351–358. 29 indexed citations

9.

Bowman, Christopher, et al.. (2010). Embryo‐fetal developmental toxicity of figitumumab, an anti‐insulin‐like growth factor‐1 receptor (IGF‐1R) monoclonal antibody, in cynomolgus monkeys. Birth Defects Research Part B Developmental and Reproductive Toxicology. 89(4). 326–338. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact